[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"oxygen-saturation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:oxygen-saturation":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,39,69,89,115,149,173,210],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100610953","nellcor-investigational-device-sitting-walking-study-100610953",false,"NCT07234279","Nellcor™ Investigational Device Sitting-Walking Study","Feasibility of the Investigational Nellcor™ Investigational Device During Non-Motion and Walking Motion Conditions in Adult Volunteers","Inclusion Criteria:\n\n* Male or female participants ≥18 years of age, and \\\u003C75 years of age.\n* Participant is able to participate for the duration of the study\n* Participant is willing to sign an informed consent form (ICF)\n* Participant weighs \\> 40kg\n* Participants must be a non-smoker or not have smoked within 36 hours prior to the study\n\nExclusion Criteria:\n\n* Participant self-reported prior injury or trauma to fingers or hands, which in the opinion of the investigator, may change blood flow or vascular supply and affect the ability to test sensors\n* Physiologic abnormalities that prevent proper application of pulse oximetry sensor\n* Severe contact allergies that cause a reaction to standard adhesive materials such as those found in medical sensors and electrodes\n* Individuals of childbearing potential who are self-reported as pregnant, or who are self-reported as trying to get pregnant\n* Morbid obesity (defined as BMI \\> 39.5)\n* Weight \\> 136 kg\n* Participants who self-report problems of unsteadiness or imbalance issues and\u002For who are unable to walk on a treadmill without holding onto the handrails\n* Participant self-reported known heart or cardiovascular conditions such as:\n* Uncontrolled hypertension (Systolic pressure ≥ 140mmHg or Diastolic pressure \\> 90mmHg on 3 consecutive readings day of screening)\n* Heart arrhythmias other than sinus arrhythmia (Self-reported and\u002For as identified on ECG day of screening).\n* History of heart attack, blocked artery, history of myocardial ischemia, angina, myocardial infarction, congestive heart failure, cardiomyopathy, stroke, transient ischemic attack, or carotid artery disease\n* Participants with self-reported clotting disorders, such as:\n* History of bleeding disorders or personal history of prolonged bleeding from injury\n* History of blood clots\n* Hemophilia\n* Current use of prescription blood thinner\n* Participants with other self-reported, known health conditions, such as:\n* Diabetes\n* Thyroid disease\n* Kidney disease \u002F chronic renal impairment\n* History of seizures (except childhood febrile seizures), epilepsy, or unexplained syncope\n* Recent history of frequent migraine headaches, as determined medically relevant by the PI\n* History of head injury, as determined medically relevant by the PI\n* Cancer \u002F chemotherapy\n* Sickle cell disease\n* History of hospital admission or a surgical procedure in the 60 days prior to study enrollment (self-reported)\n* Participants with any contraindications to protocol specific repositioning techniques\n* Unwillingness or inability to remove colored nail polish from test digit(s)\n* Participants who have self-reported health conditions beyond what is captured in the prior exclusion criteria, which in the opinion of the Investigator and\u002For Clinical Staff would classify the participant as medically unsuitable",true,"ALL","18 Years","75 Years",{"count":21,"type":22},30,"ESTIMATED","OBSERVATIONAL","To examine pulse rate and blood oxygen saturation accuracy of the Nellcor™ Investigational Device during non-motion and walking motion conditions in a diverse patient population through non-invasive means",[26],"Oxygen Saturation","NOT_YET_RECRUITING","2026-05-12",{"date":30,"type":31},"2026-05-14","ACTUAL",{"date":33,"type":22},"2026-06",{"date":35,"type":22},"2026-07",{"name":37,"class":38},"Medtronic - MITG","INDUSTRY",{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":46,"enrollmentInfo":47,"targetDuration":49,"studyType":23,"phases":4,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":68},"100630411","oxygenation-in-posterior-stabilization-surgery-100630411","NCT07487324","Oxygenation in Posterior Stabilization Surgery","Factors Determining Oxygenation in Posterior Stabilization Surgery: The Role of Positioning and Mechanical Ventilation Parameters","Inclusion Criteria:\n\nPatients aged 18 to 75 years Patients classified as ASA physical status I, II, or III according to the American Society of Anesthesiologists Patients undergoing posterior stabilization surgery Patients who voluntarily agreed to participate in the study Patients with a body mass index (BMI) \\\u003C35 kg\u002Fm² Patients followed with a standard mechanical ventilation procedure\n\nExclusion Criteria:\n\n* \\- ASA 4 olarak değerlendirilenler\n* Anestezik ajan alerjisi olanlar\n* Kanama diatezi bozukluğu olanlar\n* Cerrahi süresi 3 saatin üstünde olanlar\n* Bilinen ileri akciğer hastalığı olanlar (intertisyel akciğer hastalığı, ileri düzey KOAH, ileri düzey astım vb)\n* VKI≥35 olanlar\n* Obstrüktif uyku apne sendromu tanısı olanlar\n* Toraks deformitesi olanlar\n* Ciddi kalp yetmezliği öyküsü olanlar (EF\\\u003C30)\n* Şiddetli anemi öyküsü olanlar (Hg\\\u003C8 mg\u002Fdl)\n* Cerrahi operasyon sırasında kan transfüzyonu ihtiyacı olan hastalar","80 Years",{"count":48,"type":22},50,"1 Day","This study aims to evaluate the effects of prone positioning on oxygenation, ventilation, and hemodynamic parameters in patients undergoing posterior stabilization surgery under general anesthesia. By comparing routine anesthesia and monitoring data obtained in the supine and prone positions, the study seeks to determine how positional changes influence respiratory mechanics and perioperative physiological stability.",[52,26],"Oxygen",[54,55,56,57],"oxygenation","Posterior Stabilization Surgery","Mechanical Ventilation Parameters","optic nerve sheath diamater","2026-03-17",{"date":60,"type":31},"2026-03-23",{"date":62,"type":22},"2026-04-01",{"date":64,"type":22},"2026-11-15",{"name":66,"class":67},"Sakarya University","OTHER",1,{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":4,"eligibilityCriteria":74,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":75,"enrollmentInfo":76,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":78,"conditions":79,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":68},"100587227","hand-perfusion-and-pulse-oximetry-performance-100587227","NCT06925646","Hand Perfusion and Pulse Oximetry Performance","Inclusion Criteria:\n\n* Healthy adult men and women of all races and ethnic backgrounds recruited from faculty and staff of the Mayo Medical Center and from Rochester, MN and surrounding communities.\n* Equal number of male and female participants to address potential sex differences in physiology.\n* We will intentionally recruit subjects with dark skin because of the issues surrounding accuracy of pulse oximetry and skin tone.\n* Non-smokers\n* BMIs between 18-30 kg·m-2.\n* Female subjects will be non-pregnant.\n* Free of cardiopulmonary diseases or other conditions and\u002For taking medications that might affect pulse oximeter-based estimates of arterial saturation.\n* All inclusion and exclusion criteria are at the discretion of the Principal Investigator.\n* At least 8 of the subjects will have Fitzpatrick Skin Type of IV to VI.\n\nExclusion Criteria:\n\n• Children under the age of 18 will not be studied. We will exclude children less than 18 years of age because they are unable to give consent, and because these studies are non-therapeutic.","65 Years",{"count":77,"type":22},20,"The purpose of this study is to compare oxygen saturation measurement readings from manufactured pulse oximetry devices to the oxygen saturation measurements of arterial blood samples drawn at the same time of measurements.",[26],"2026-03-11",{"date":82,"type":31},"2026-03-13",{"date":84,"type":22},"2026-09-01",{"date":86,"type":22},"2028-10-01",{"name":88,"class":67},"Mayo Clinic",{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":93,"acronym":94,"eligibilityCriteria":95,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":96,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":98,"conditions":99,"keywords":4,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":68},"100440972","remote-investigation-and-assessment-of-vital-signs-100440972","NCT05022264","Remote Investigation and Assessment of Vital Signs","RIA-VS","Inclusion Criteria:\n\nThe same subject can't be enrolled more than once with the exception that subjects in WP1 may also be recruited to WP2.\n\nWP1+WP2:\n\n1. The patient is attending primary or secondary health care.\n2. The subject has provided informed consent.\n3. Age ≥18 years.\n4. Fluent in Swedish, English, Somali or Arabic (we will translate the patient information and ensure an interpreter can be present for translating questions).\n5. The patient is willing and able to give informed consent \".\n6. The investigator determines that the new study device, and the reference methods, can be used as intended with adequate safety.\n7. The delay in the management of each patient introduced by this study is approximately 15-20 minutes. Patients deemed being in such a severe medical condition that 15-20 minutes of delay is deemed detrimental will not be included.\n\nWP3:\n\n1. Patients attending primary health care.\n2. The subject has provided informed consent.\n3. Age ≥18 years.\n4. Fluent in Swedish, English, Somali or Arabic (we will translate the patient information and ensure an interpreter can be present for translating questions).\n5. The patient is willing and able to give informed consent .\n6. The investigator determines that the new study device, and the reference methods, can be used as intended with adequate safety.\n7. The delay in the management of each patient introduced by this study is approximately 15-20 minutes. Patients deemed being in such a severe medical condition that 15-20 minutes of delay is deemed detrimental will not be included.\n\nExclusion Criteria:\n\nSubjects are free to withdraw from the study at any point. Subjects will also be withdrawn from the study in case of unexpected depressed level of consciousness from inclusion up until all investigations are completed (during approximately 15-20 minutes). Any reduction in consciousness will incur that the subject is withdrawn.",{"count":97,"type":22},860,"The vital signs (pulse, systolic and diastolic blood pressure, respiratory rate, oxygen saturation and body temperature) are critical in assessing the severity and prognosis of infections. The devices used today for measuring the vital signs have to be in physical contact with the patients. There is an apparent risk of transferring infections from one patient to the next (or to healthcare professionals). Accurately obtaining vital signs is also important when managing other categories of patients where it may be relevant to obtain some of the vital signs such as pulse and blood pressure.\n\nThis project aims to evaluate a new camera-based system for contactless measurement of vital signs.",[100,101,102,26,103],"Blood Pressure","Pulse Rate","Respiratory Rate","Body Temperature","RECRUITING","2025-09-16",{"date":107,"type":31},"2025-09-22",{"date":109,"type":31},"2022-03-01",{"date":111,"type":22},"2027-06-30",{"name":113,"class":114},"Vastra Gotaland Region","OTHER_GOV",{"id":116,"slug":117,"hasResults":11,"nctId":118,"briefTitle":119,"officialTitle":120,"acronym":4,"eligibilityCriteria":121,"healthyVolunteers":16,"sex":17,"minAge":122,"maxAge":123,"enrollmentInfo":124,"targetDuration":4,"studyType":126,"phases":127,"briefSummary":129,"conditions":130,"keywords":134,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":140,"lastUpdatePostDateStruct":141,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":147,"locationsCount":68},"100381894","effect-of-kangaroo-care-on-test-weighing-100381894","NCT04252547","Effect of Kangaroo Care on Test Weighing","The Effect Of Kangaroo Mother Care On Test Weighing In Preterm Infants","Inclusion Criteria:\n\n\\- Agreeing to participate in the study for parents.\n\nThe inclusion criteria for infants were as follows;\n\n* Attaining to oral feeding by the physician in the neonatal intensive care unit\n* Being born at 26-36+6 gestational week which is determined according to the mother's last period cycle\n* Being at 32-39+6 postmenstrual week during the time they are included in the study\n* Having body weight of 1500 grams and above\n* Being breastfed at least once\n* Having no health problems other than being preterm\n\nExclusion Criteria:\n\nThe exclusion criteria for infants were as follows;\n\n* Suffering from gastrointestinal, neurological or genetic diseases (such as necrotizing enterocolitis, intracranial bleeding, hydrocephalia, omphalocele, down syndrome, gastroschisis) and other diseases\n* Having a condition obstructing oral feeding (such as cleft palate, cleft lip, facial muscle paralysis, craniofacial abnormalities etc.)\n* Receiving oxygen support","32 Weeks","40 Weeks",{"count":125,"type":22},46,"INTERVENTIONAL",[128],"NA","The study will be conducted with the Crossover Randomized Controlled Method. The infants who have attained oral feeding in the neonatal intensive care unit will be divided into two groups via randomization in the computer environment. After the randomization, kangaroo care will be applied to the infants in Group 1 during the first feeding hour when they are included in the study and they will be breastfed by their mothers without any other application during the next feeding. On the other hand, no application will be performed on the infants in Group 2 during the first feeding hour when they are included in the study and kangaroo care will be applied to them during the second feeding hour. The infants in both groups will be breastfed by their mothers during the feeding hours.",[131,132,26,133],"Kangaroo Care","Weight Gain","Heart Rate",[135,136,137,138,139],"kangaroo care","test weighing","Heart rate","oxygen saturation","preterm infants","2025-04-29",{"date":142,"type":31},"2025-05-02",{"date":144,"type":31},"2024-06-09",{"date":146,"type":22},"2026-01-09",{"name":148,"class":67},"Istanbul University - Cerrahpasa",{"id":150,"slug":151,"hasResults":11,"nctId":152,"briefTitle":153,"officialTitle":154,"acronym":4,"eligibilityCriteria":155,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":156,"targetDuration":158,"studyType":23,"phases":4,"briefSummary":159,"conditions":160,"keywords":4,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":164,"lastUpdatePostDateStruct":165,"startDateStruct":167,"completionDateStruct":169,"leadSponsor":171,"locationsCount":68},"100584077","local-and-systemic-oxygen-saturation-during-death-by-squats-exercise-100584077","NCT06884644","Local and Systemic Oxygen Saturation During 'Death by Squats' Exercise","Analysis of Local and Systemic Oxygen Saturation During Monotonous Exercise Using the Example of 'Death by Squats'","Inclusion Criteria:\n\n* being moderately to severely physically active al least 2 hours\u002Fweek (all types of sport are eligible)\n\nExclusion Criteria:\n\n* akute infections, musculoskeletal injuries\n* chronic cardiovascular or pulmonary diseases (in case of uncertainty, we recommend appraisal from medical personnel)",{"count":157,"type":22},100,"24 Months","During the exercise intervention \"Death by Squats\", which compasses body weight squats until maximum exertion, 25-30 subjects shall be tested for heart rate, the oxygen saturation of the vastus medialis and the triceps, resting and at maximum exertion blood lactate, as well as the rate of perceived exertion on the borg scale. At the end, all should indicate their primary reason for stopping (local fatigue, systemic fatigue, time constraints, motivational deficit).",[26,161,162,163],"Fatigue","Anaerobic Threshold","Quadriceps Muscle","2025-03-18",{"date":166,"type":31},"2025-03-19",{"date":168,"type":31},"2025-02-08",{"date":170,"type":22},"2025-12",{"name":172,"class":67},"Bundeswehr University Munich",{"id":174,"slug":175,"hasResults":11,"nctId":176,"briefTitle":177,"officialTitle":178,"acronym":179,"eligibilityCriteria":180,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":18,"enrollmentInfo":181,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":183,"conditions":184,"keywords":188,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":201,"lastUpdatePostDateStruct":202,"startDateStruct":204,"completionDateStruct":206,"leadSponsor":208,"locationsCount":68},"100473975","validation-of-vital-signs-recording-with-vt-patch-connected-devices-in-children-100473975","NCT05451875","Validation of Vital Signs Recording With VT-Patch Connected Devices in Children","Validation of Vital Signs Recording With VT-Patch® Connected Devices in Children","VT","Inclusion Criteria:\n\n* PICU monitoring for the next 24 hours\n\nExclusion Criteria:\n\n* Recent cardiac or thoracic surgery\n* Thoracic skin lesion that contraindicates the VT patch\n* No parental consent\n* Intermittent presence of one study observer in the patient room considered inappropriate by the physician or the nurse in charge because of the child's medical condition",{"count":182,"type":22},48,": Patient readmission to PICU is a major point of concern for physicians because, although being a rare event, it has been strongly associated with more morbidity and death. Patient monitoring once they have left the PICU is drastically modified, and small connected devices could be an option to early identify patients at risk of PICU readmission. Such devices have been manufactured for the recording of vital signs in adults, but they do not exist for children.\n\nBesides, studies have recently shown that devices that use optical sensors may be less accurate in individuals with dark skin pigmentation since dark skin tones impose a limitation on optical biometric sensing. The wearable and medical device industry has not sufficiently addressed this issue yet. This is one of the main challenges that need to be addressed in this area to make sure the connected devices using this technology will work with all different skin colours including very dark skin.",[185,26,186,187,133,102],"Vital Signs","Children","Intensive Care Unit",[189,190,191,192,193,137,194,195,196,186,197,198,199,200],"Vital signs","SPO2","ECG","Continuous","Skin temperature","VitalTracer","Wearable","All-in-one","PICU","Different Skin Color","Dark skin color","Monk Scale","2025-03-05",{"date":203,"type":31},"2025-03-10",{"date":205,"type":31},"2025-02-03",{"date":207,"type":22},"2025-12-31",{"name":209,"class":38},"VitalTracer Ltd.",{"id":211,"slug":212,"hasResults":11,"nctId":213,"briefTitle":214,"officialTitle":215,"acronym":4,"eligibilityCriteria":216,"healthyVolunteers":16,"sex":17,"minAge":217,"maxAge":18,"enrollmentInfo":218,"targetDuration":49,"studyType":23,"phases":4,"briefSummary":220,"conditions":221,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":223,"lastUpdatePostDateStruct":224,"startDateStruct":226,"completionDateStruct":228,"leadSponsor":230,"locationsCount":68},"100564252","comparison-of-oxygen-saturation-measurements-using-different-glove-colors-in-children-100564252","NCT06626763","Comparison of Oxygen Saturation Measurements Using Different Glove Colors in Children","Comparison of Oxygen Saturation Measurements Using Different Glove Colors in Children: A Preventive Method for Infection?","Inclusion Criteria:\n\n* Children between the ages of 3-18,\n* The parent\u002Flegal guardian or the child himself\u002Fherself agrees to participate in the study,\n* Arterial blood gas measurement was performed,\n\nExclusion Criteria:\n\n* The finger has a skin condition,\n* Having nail polish on your fingernails,\n* Having a severed finger,","3 Years",{"count":219,"type":22},68,"The aim of this study was to determine the effect of different colored gloves on oxygen saturation in pediatric patients whose oxygen saturation was measured by pulse oximetry in pediatric emergency department. The population of the study, which is planned as a prospective cohort study, will consist of children between the ages of 3-18 years who underwent oxygen saturation measurements in the pediatric emergency clinic of İzmir Bakırçay University Cigli and Training and Research Hospital between October 2024 and October 2025.",[222,26,186],"Infection","2024-10-03",{"date":225,"type":31},"2024-10-04",{"date":227,"type":22},"2024-10-08",{"date":229,"type":22},"2025-10-08",{"name":231,"class":67},"Izmir Katip Celebi University"]